FUSO PHARMACEUTICAL INDUSTRIES financial statements, including revenue, expenses, profit, and loss
The total revenue of 4538 for the last quarter is 15.41 B JPY, and it's 10.70% higher compared to the previous quarter. The net income of Q3 23 is 510.00 M JPY.